Compounds > 6-hydroxydopa
Page last updated: 2024-09-02

6-hydroxydopa and Malignant Melanoma

6-hydroxydopa has been researched along with Malignant Melanoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byers, L; Ratliff, J; Wick, MM1
Hansson, C; Rorsman, H; Rosengren, E; Wittbjer, A1
Cohen, G; Morrison, ME; Yagi, MJ1

Other Studies

3 other study(ies) available for 6-hydroxydopa and Malignant Melanoma

ArticleYear
Selective toxicity of 6-hydroxydopa for melanoma cells.
    The Journal of investigative dermatology, 1979, Volume: 72, Issue:2

    Topics: Animals; Cells, Cultured; Cricetinae; Dihydroxyphenylalanine; Growth Inhibitors; Melanoma; Mice; Neoplasms, Experimental

1979
Production of 6-hydroxydopa by human tyrosinase.
    Acta dermato-venereologica, 1985, Volume: 65, Issue:2

    Topics: Catalysis; Catechol Oxidase; Cell Line; Culture Media; Dihydroxyphenylalanine; Humans; Melanoma; Monophenol Monooxygenase

1985
In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells.
    Proceedings of the National Academy of Sciences of the United States of America, 1985, Volume: 82, Issue:9

    Topics: Animals; Cell Survival; Cells, Cultured; Dihydroxyphenylalanine; Leukemia L1210; Mammary Neoplasms, Experimental; Melanoma; Mice; Monophenol Monooxygenase

1985